Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice

Mol Brain. 2013 Aug 11:6:35. doi: 10.1186/1756-6606-6-35.

Abstract

Background: In autosomal recessive early-onset Parkinsonism (PARK2), the pathogenetic process from the loss of function of a ubiquitin ligase parkin to the death of dopamine neurons remains unclear. A dominant hypothesis attributes the neurotoxicity to accumulated substrates that are exempt from parkin-mediated degradation. Parkin substrates include two septins; SEPT4/CDCrel-2 which coaggregates with α-synuclein as Lewy bodies in Parkinson's disease, and its closest homolog SEPT5/CDCrel-1/PNUTL1 whose overload with viral vector can rapidly eliminate dopamine neurons in rats. However, chronic effects of pan-neural overload of septins have never been examined in mammals. To address this, we established a line of transgenic mice that express the largest gene product SEPT4(54kDa) via the prion promoter in the entire brain.

Results: Histological examination and biochemical quantification of SEPT4-associated proteins including α-synuclein and the dopamine transporter in the nigrostriatal dopamine neurons found no significant difference between Sept4(Tg/+) and wild-type littermates. Thus, the hypothetical pathogenicity by the chronic overload of SEPT4 alone, if any, is insufficient to trigger neurodegenerative process in the mouse brain. Intriguingly, however, a systematic battery of behavioral tests revealed unexpected abnormalities in Sept4(Tg/+) mice that include consistent attenuation of voluntary activities in distinct behavioral paradigms and altered social behaviors.

Conclusions: Together, these data indicate that septin dysregulations commonly found in postmortem human brains with Parkinson's disease, schizophrenia and bipolar disorders may be responsible for a subset of behavioral abnormalities in the patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal* / drug effects
  • Circadian Rhythm / drug effects
  • Dopamine / metabolism
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Exploratory Behavior / drug effects
  • Humans
  • Methamphetamine / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neostriatum / drug effects
  • Neostriatum / enzymology
  • Neostriatum / pathology
  • Nerve Degeneration / complications
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / pathology*
  • Parkinson Disease / complications
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • Peptides / metabolism
  • Protein Structure, Quaternary
  • Rats
  • Septins / chemistry*
  • Septins / metabolism*
  • Solubility
  • Substrate Specificity / drug effects
  • Tyrosine 3-Monooxygenase / metabolism
  • Ubiquitin-Protein Ligases / metabolism*
  • alpha-Synuclein / metabolism

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Peptides
  • alpha-Synuclein
  • Methamphetamine
  • Tyrosine 3-Monooxygenase
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Sept4 protein, mouse
  • Septins
  • Dopamine